Cantor Fitzgerald & Co. - Jun 30, 2025 SCHEDULE 13G Report for OnKure Therapeutics Inc. Class A Common Stock, par value $0.0001 per share (OKUR)

Filing Manager
CANTOR FITZGERALD & CO.
Reporting Manager
Cantor Fitzgerald Securities
Security
OnKure Therapeutics Inc. Class A Common Stock, par value $0.0001 per share
Symbol
OKUR
Shares outstanding
12.9M shares
Disclosed Ownership
670K shares
Ownership
5.2%
Form type
SCHEDULE 13G
Date filed
8/14/2025, 04:05 PM
Date of event
Jun 30, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Cantor Fitzgerald Securities 5.2% 670K 0 670K /s/ Pascal Bandelier Pascal Bandelier/Co-Chief Executive Officer
Cantor Fitzgerald & Co. 5.2% 670K 0 670K /s/ Pascal Bandelier Pascal Bandelier/Co-Chief Executive Officer
Cantor Fitzgerald, L.P. 5.2% 670K 0 670K /s/ Brandon Lutnick Brandon Lutnick/Chairman & Chief Executive Officer
CF Group Management, Inc. 5.2% 670K 0 670K /s/ Brandon Lutnick Brandon Lutnick/Chairman & Chief Executive Officer